These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6495327)

  • 1. Consecutive bestatin-hormone regimen induces redifferentiation of cancer cells in vitro.
    Okuyama S; Mishina H
    Tohoku J Exp Med; 1984 Aug; 143(4):501-2. PubMed ID: 6495327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redifferentiation of cancer cells: bestatin, estradiol, and prostaglandin D2.
    Okuyama S; Mishina H; Maki T
    Ann N Y Acad Sci; 1985; 459():293-307. PubMed ID: 3868328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone-induced functional response in mammary glands and mammary tumours.
    Heise E; Görlich M; Kleitke C; Bacigalupo G
    Eur J Cancer (1965); 1971 Feb; 7(1):71-6. PubMed ID: 5576731
    [No Abstract]   [Full Text] [Related]  

  • 4. Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):31-4. PubMed ID: 3870142
    [No Abstract]   [Full Text] [Related]  

  • 5. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of surgery, hormones, and nutrition on mammary cancer induced by 3-methylcholanthrene in female Wistar rats.
    Gruenstein M; Thatcher D; Acuff M; Shimkin MB
    Cancer Res; 1966 Jun; 26(6 Pt 2):579-86. PubMed ID: 5939560
    [No Abstract]   [Full Text] [Related]  

  • 7. [The potentials for combined estrogen-androgen therapy in the postmenopause].
    Kolarov G; Nalbanski B; Nikolov A; Orbetsova M; Filipov E
    Akush Ginekol (Sofiia); 1999; 38(2):48-51. PubMed ID: 10730390
    [No Abstract]   [Full Text] [Related]  

  • 8. Decrease in saturation density of mammalian carcinoma cell culture during exposure to bestatin, a clinically applicable agent.
    Okuyama S; Mishina H
    Tohoku J Exp Med; 1984 Mar; 142(3):349-50. PubMed ID: 6729813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and morphological responses of normal and neoplastic mammary tissue to hormonal treatment.
    Hilf R; Michel I; Bell C
    Recent Prog Horm Res; 1967; 23():229-95. PubMed ID: 4876481
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences of the growth of mouse teratocarcinoma OTT6050 induced by various sex hormone treatments in vivo.
    Kubota K; Kubota R; Matsuzawa T
    Oncology; 1984; 41(3):217-21. PubMed ID: 6203075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of hormonal responsiveness in vitro. Effect of sex steroids on non-malignant rat cells compared with the effect on cells from rat tumours.
    Aspegren K
    Acta Pathol Microbiol Scand A; 1976 Mar; 84(2):198-200. PubMed ID: 176869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of mammary epithelial cell differentiation and inhibition of dimethylbenz(A)anthracene-induced mammary tumour by co-administration of a pure antiestrogen ICI 182,780 and testosterone enanthate.
    Chan TW; Mark G; Huynh H
    Int J Oncol; 2001 Aug; 19(2):263-9. PubMed ID: 11445837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steroid hormones in the menopause. Case report contribution to the therapeutic problem of climacteric psychoses with sex hormones].
    Radmayr E
    Wien Med Wochenschr; 1968 Feb; 118(7):130-5. PubMed ID: 4299432
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination therapy of 3-methylcholanthrene-induced mammary carcinoma in rats: effect of chemotherapy, ovariectomy, and food restriction.
    Gropper L; Shimkin MB
    Cancer Res; 1967 Jan; 27(1):26-32. PubMed ID: 6071371
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Teller MN; Kaufman RJ; Bowie M; Stock CC
    Cancer Res; 1969 Feb; 29(2):349-52. PubMed ID: 5765416
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone treatment of advanced renal cell carcinoma.
    Raghavaiah NV
    Urology; 1982 Feb; 19(2):123-6. PubMed ID: 7058601
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hemiplegia with sex hormones].
    BUHLER F
    Med Klin; 1959 Apr; 54(16):772-3. PubMed ID: 13656361
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of bestatin on syngeneic tumors in mice.
    Abe F; Shibuya K; Uchida M; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1984 Jan; 75(1):89-94. PubMed ID: 6586596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: a review.
    Mori T; Nagasawa H; Bern HA
    J Environ Pathol Toxicol; 1979 Dec; 3(1-2):191-205. PubMed ID: 397957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement.
    Brincat M; Moniz CF; Kabalan S; Versi E; O'Dowd T; Magos AL; Montgomery J; Studd JW
    Br J Obstet Gynaecol; 1987 Feb; 94(2):126-9. PubMed ID: 3828252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.